Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus by Schmiegelow, Kjeld, Prof, Attarbaschi, Andishe, MD, Barzilai, Shlomit, MD, Escherich, Gabriele, MD, Frandsen, Thomas Leth, MD, Halsey, Christina, MD, Hough, Rachael, MD, Jeha, Sima, Prof, Kato, Motohiro, MD, Liang, Der-Cherng, MD, Mikkelsen, Torben Stamm, MD, Möricke, Anja, MD, Niinimäki, Riitta, MD, Piette, Caroline, MD, Putti, Maria Caterina, MD, Raetz, Elizabeth, Prof, Silverman, Lewis B, MD, Skinner, Roderick, Prof, Tuckuviene, Ruta, MD, van der Sluis, Inge, MD, Zapotocka, Ester, MD

Get full text

Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study by Pui, Ching-Hon, Prof, Pei, Deqing, MS, Coustan-Smith, Elaine, MS, Jeha, Sima, Prof, Cheng, Cheng, Prof, Bowman, W Paul, MD, Sandlund, John T, Prof, Ribeiro, Raul C, Prof, Rubnitz, Jeffrey E, Prof, Inaba, Hiroto, MD PhD, Bhojwani, Deepa, MD, Gruber, Tanja A, MD PhD, Leung, Wing H, Prof, Downing, James R, Prof, Evans, William E, Prof, Relling, Mary V, Prof, Campana, Dario, Prof

Get full text